Switch theme
Sign up to access all valuation multiples
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
1995
298
LTM Revenue $300M
LTM EBITDA $35.0M
$175M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Tactile Medical has a last 12-month revenue (LTM) of $300M and a last 12-month EBITDA of $35.0M.
In the most recent fiscal year, Tactile Medical achieved revenue of $293M and an EBITDA of $32.4M.
Tactile Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Tactile Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $300M | XXX | $293M | XXX | XXX | XXX |
| Gross Profit | $222M | XXX | $217M | XXX | XXX | XXX |
| Gross Margin | 74% | XXX | 74% | XXX | XXX | XXX |
| EBITDA | $35.0M | XXX | $32.4M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| EBIT | $20.2M | XXX | $22.2M | XXX | XXX | XXX |
| EBIT Margin | 7% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $15.4M | XXX | $17.0M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Tactile Medical's stock price is $10.
Tactile Medical has current market cap of $230M, and EV of $175M.
See Tactile Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $175M | $230M | XXX | XXX | XXX | XXX | $0.64 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Tactile Medical has market cap of $230M and EV of $175M.
Tactile Medical's trades at 0.6x EV/Revenue multiple, and 5.4x EV/EBITDA.
Equity research analysts estimate Tactile Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Tactile Medical has a P/E ratio of 14.9x.
See valuation multiples for Tactile Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $230M | XXX | $230M | XXX | XXX | XXX |
| EV (current) | $175M | XXX | $175M | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | 5.0x | XXX | 5.4x | XXX | XXX | XXX |
| EV/EBIT | 8.7x | XXX | 7.9x | XXX | XXX | XXX |
| EV/Gross Profit | 0.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 14.9x | XXX | 13.5x | XXX | XXX | XXX |
| EV/FCF | 4.8x | XXX | 4.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialTactile Medical's last 12 month revenue growth is 7%
Tactile Medical's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.7M for the same period.
Tactile Medical's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Tactile Medical's rule of X is 29% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Tactile Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 1% | XXX | 14% | XXX | XXX | XXX |
| Rule of 40 | 16% | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 29% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.0M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.7M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 38% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 66% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Tactile Medical acquired XXX companies to date.
Last acquisition by Tactile Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Tactile Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Tactile Medical founded? | Tactile Medical was founded in 1995. |
| Where is Tactile Medical headquartered? | Tactile Medical is headquartered in United States of America. |
| How many employees does Tactile Medical have? | As of today, Tactile Medical has 298 employees. |
| Who is the CEO of Tactile Medical? | Tactile Medical's CEO is Ms. Sheri Louise Dodd. |
| Is Tactile Medical publicy listed? | Yes, Tactile Medical is a public company listed on NAS. |
| What is the stock symbol of Tactile Medical? | Tactile Medical trades under TCMD ticker. |
| When did Tactile Medical go public? | Tactile Medical went public in 2016. |
| Who are competitors of Tactile Medical? | Similar companies to Tactile Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Tactile Medical? | Tactile Medical's current market cap is $230M |
| What is the current revenue of Tactile Medical? | Tactile Medical's last 12 months revenue is $300M. |
| What is the current revenue growth of Tactile Medical? | Tactile Medical revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Tactile Medical? | Current revenue multiple of Tactile Medical is 0.6x. |
| Is Tactile Medical profitable? | Yes, Tactile Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Tactile Medical? | Tactile Medical's last 12 months EBITDA is $35.0M. |
| What is Tactile Medical's EBITDA margin? | Tactile Medical's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Tactile Medical? | Current EBITDA multiple of Tactile Medical is 5.0x. |
| What is the current FCF of Tactile Medical? | Tactile Medical's last 12 months FCF is $36.2M. |
| What is Tactile Medical's FCF margin? | Tactile Medical's last 12 months FCF margin is 12%. |
| What is the current EV/FCF multiple of Tactile Medical? | Current FCF multiple of Tactile Medical is 4.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
